MIST PPF Study now enrolling
Learn More
About
Our Purpose
Our Team
Investors
Science
Our Approach
Inhaled Advantage
Publications
Pipeline
Overview
AP01
AP02
AP03
Patients & Caregivers
Commitment
Clinical Trials
Expanded Access Policy
Investors & Media
Press Releases
Events
Culture & Careers
Overview
Culture
Benefits
Job Opportunities
Contact
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial
West A, Chaudhuri N, Barczyk A, et al. (2023)
Thorax